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Ergot alkaloids produced by a fungal endophyte (Epichloë coenophiala; formerly
Neotyphodium coenophialum) that infects tall fescue (Lolium arundinaceum) can induce
persistent constriction of the vasculature in ruminants, hindering their capability to ther-
mo-regulate core body temperature. There is evidence that isoflavones produced by legumes 
can relax the vasculature, which suggests that they could relieve ergot alkaloid-induced 
vasoconstriction and mitigate the vulnerability to severe heat stress in ruminants that graze
tall fescue. To test if isoflavones can relieve alkaloid-induced vasoconstriction, two pen
experiments were conducted with rumen-fistulated goats (Capra hircus) to determine with
ultrasonograpy if isoflavones can (1) promote vascular compliance by countering alkaloid-
induced vasoconstriction and (2) relieve already imposed alkaloid-induced vasoconstriction.
Goats were fed ad  libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum
pratense) hay prior to conducting the experiments. Measures of carotid and interosseous
luminal areas were obtained pre- (baseline) and post-ruminal infusions in both experiments
with goats being fed the hay, and for blood flow rate in the carotid artery in Experiment 2.
Responses to infusion treatments were evaluated as proportionate differences from base-
line measures. Peak systolic velocity, pulsatility index, and heart rate were measured on the
last day on treatment (DOT) in Experiment 1, and on all imaging sessions during Experiment
2. For Experiment 1, rumens were infused with ground toxic fescue seed and isoflavones
in Phase A and with only the toxic seed in Phase B. The infusion treatments were switched
between phases in Experiment 2, which employed a fescue seed extract having an ergot
alkaloid composition equivalent to that of the ground seed used in Experiment 1. During
Experiment 1, luminal areas of carotid and interosseous arteries in Phase A did not deviate
(P > 0.1) from baselines over 1, 2, 3, and 4 DOT, but the areas of both declined linearly from
baselines over 1, 2, 3, and 4 DOT in Phase B. By 6, 7, and 8 DOT in Experiment 2, luminal
areas of the arteries and flow rate declined from baselines with infusions with the only seed
extract in Phase A, but luminal areas and flow rate increased over 4, 5, and 6 DOT with the
additional infusion of isoflavones. Peak systolic velocity and heart rate were not affected by
treatment in either experiment, but were highest when infused with only ergot alkaloids in
both experiments. Treatment with isoflavones was demonstrated to relax the carotid and
interosseous arteries and reduce resistance to blood flow. Results indicate that isoflavones
can relax persistent vasoconstriction in goats caused by consumption of ergot alkaloids,
and mitigate the adverse effect that ergot alkaloids have on dry matter intake.
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inTrODUcTiOn
Tall fescue (Lolium arundinaceum) is a cool-season perennial 
grass that covers ~15 million hectares in the eastern half of the 
USA and is extensively utilized for livestock grazing. The grass 
is productive and tolerant of environmental stresses, which has 
been attributed to the presence of a fungal endophyte (Epichloë 
coenophiala) that infects most plants of tall fescue (1). However, 
ergot alkaloid toxins are also produced by the endophyte, and 
they cause a toxicosis in grazing livestock. Signs of “fescue toxi-
cosis” include poor weight gain and reproductive performances, 
elevated body temperature, labored respiration, and decreased 
serum prolactin (2, 3).
Ergot alkaloids bind biogenic amine receptors in the vascula-
ture (4) to induce persistent vasoconstriction (5) that incapacitates 
the animal’s ability to regulate core body temperature (6, 7). Cattle 
(5, 8), sheep (9), horses (10), and goats (11) have been reported 
to vasoconstrict when exposed to ergot alkaloids. Therefore, the 
vasculatures of these livestock species are vulnerable to ergot 
alkaloid-induced vasoconstriction. Ergot alkaloids also bind D2 
receptors of the anterior pituitary gland to reduce secretion of 
prolactin (3, 4).
Isoflavones are phytoestrogens commonly found in legumes 
and can have estrogenic activity in mammals (12). Isoflavones 
have been used as a treatment for ameliorating hot flashes in 
postmenopausal women (13, 14). Cruz et al. (15) used in vitro 
techniques with small arteries collected from subcutaneous 
circulation of men with and without coronary heart disease to 
determine a vaso-relaxation response with exposure to phytoes-
trogens, resveratrol and genistein. Relaxation of the vasculature 
from exposure to isoflavones has been associated with agonist 
activity of isoflavones at β-adrenergic receptors in the vasculature 
endothelium to stimulate synthesis of nitric oxide that mediates 
vaso-relaxation (13–16). Recently, Shappell et  al. (17) reported 
an additive effect of combining estradiol implants with feeding 
soybean hulls on the estrogenic activity of serum from steers 
grazing toxic tall fescue. Although it could not be concluded, the 
mitigation of fescue toxicosis observed with this treatment com-
bination (18) could have been related to estrogenic activity with 
the treatment combinations being above a threshold for relief of 
vasoconstriction to occur. It could be possible that β-agonist activ-
ity of isoflavones could ameliorate the persistent vasoconstriction 
caused by ergot alkaloids. Therefore, a pen study was conducted 
using color Doppler and B-mode ultrasonography to determine 
if treatment of wether goats with isoflavones can mediate relaxa-
tion of their carotid and interosseous arteries during and after the 
occurrence of ergot alkaloid-induced vasoconstriction.
MaTerials anD MeThODs
Two independent experiments were conducted in the basement 
of the Garrigus Building on the University of Kentucky Campus 
using in-door pens maintained at ambient temperature of ~21°C. 
The same set of six Spanish, wether goats that were ~2-year old 
and with rumen fistulas were used in both experiments. Initial 
body weights for Experiments 1 and 2 averaged 36.3 ± 2.6 (SD) 
and 38.6 ± 5.0 kg, respectively. Goats were weighed initially and 
periodically to make sure that body weights of the mature goats 
were stable during the experiment. Handling of goats and data 
collection followed procedures approved by the University of 
Kentucky Institutional Animal Care and Use Committee (proto-
col number 2013-1152).
With the low number of fistulated goats available for the study 
and the possibility of amelioration of ergot alkaloid-induced vaso-
constriction being subtle and over a long period of time, it was 
decided to keep all goats on the same infusion treatment within 
a phase for each experiment. Carry-over effects of ergot alkaloids 
are not understood, so the goats were kept on the non-toxic hay 
for 78 days between the two experiments. Furthermore, conduct 
of the experiments in a controlled environment (21 ± 1°C) mini-
mized confounding effects of time and changes in environmental 
conditions.
isoflavone analysis
Promensil® (Natrol Inc., Chatsworth, CA, USA), an over-the-
counter red clover dietary supplement that has been safely 
administered to humans in clinical studies (19) was infused 
trans-ruminally as a source of isoflavones.
For assaying isoflavones in the red clover tablets (~600 mg), 
tablets were incubated in 7.5 mL water in a 50-mL tube for about 
30 min (including 10 min at 27–32°C) to dissolve other additives 
in the tablets. After a brief centrifugation (3 min, 25°C, 2200 × g), 
the supernatant was discarded. Loss of isoflavones in this first step 
was expected to be minimal because preliminary extractions in 
water had demonstrated that after 1–2 h of stirring or sonicating, 
~2.3 mg of isoflavones (6% of the expected total) was recovered.
The pellet recovered from the above centrifugation was then 
extracted after the method of Flythe and Kagan (20), but with 
volumes modified for the larger samples, and with some heat-
ing to approximate changes that might occur in the rumen. The 
pellet remaining after the water incubation was sonicated for 
30 min, 28–35°C, in 8.4 mL 85% MeOH in 0.5% aqueous acetic 
acid. This extraction solvent included an internal standard, 
consisting of 0.58 mM catechin (Sigma-Aldrich, St. Louis, MO, 
USA) prepared in MeOH. After addition of 3.6 mL water (final 
solvent composition of 60% MeOH in 0.35% aqueous acetic 
acid), samples were centrifuged (8  min, 25°C, 2200 ×  g,), and 
5  mL supernatant was filtered through a 0.45-μm hydrophilic 
membrane (GH Polypropylene, Pall Life Sciences, Ann Arbor, 
MI, USA). A portion of filtrate was diluted threefold in the same 
methanol–acetic acid solvent (to be within the range of the 
standard curve) and used for high-performance liquid chroma-
tography (HPLC) analysis. Diluted extracts were separated on an 
Agilent 1100 HPLC system equipped with a Merck LiChrospher 
RP-18 endcapped column (250 mm length × 4.6 mm i.d.), using 
separation conditions described previously (21). Isoflavones 
were monitored at 270 nm and quantified based on calibration 
curves of standards purchased from Sigma-Aldrich (biochanin 
A) or Indofine Chemical (genistein). Aglycones and their cor-
responding glycosides, if identifiable, were summed to give the 
total amounts of each isoflavone of interest. Formononetin was 
quantified based on a biochanin A calibration curve, which 
decreased the final formononetin concentrations by about 20% 
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and, thus, gave a slightly more conservative number. Genistein 
was quantified with a genistein calibration curve. Genistin, the 
genistein glucoside, was not included in the genistein quantifica-
tion because it was not detectable at the concentrations injected. 
Similarly, daidzein was not detected.
The amounts of biochanin A, formononetin, and genistein 
(representing the sum of aglycones and corresponding glycosides 
if present) were corrected for recovery, based on the amount of 
catechin recovered in extracts. Recoveries were about 80%. When 
biochanin A, formononetin, and genistein content were averaged 
among six replicates, the mean concentrations per tablet, with 
the extraction and analytical methods used, were 5.7 ± 0.7 mg 
biochanin A, 5.2 ±  1.0 mg formononetin, and 0.42 ±  0.05 mg 
genistein. These results did not include the contribution from 
the biochanin A malonylglucoside, and they underestimated the 
amount of formononetin by about 20% because formononetin 
was quantified with a biochanin A calibration curve, which has a 
higher response factor.
infusion Treatments
Rumen infusion treatments were evaluated in each experiment. 
Goats were penned as pairs and were adapted to ad  libitum 
consumption of a chopped orchardgrass (Dactylis glomerata)–
timothy (Phleum pratense) hay for a minimum of 35 days prior 
to initiation of the infusion treatments. Quantity of Promensil 
infused daily (~27 g) was set to provide 30 mg/L of biochanin 
A, the isoflavone of highest concentration in the red clover 
tablets. In Experiment 1, ground toxic endophyte-infected 
seed of “Kentucky 31” tall fescue and isoflavones were infused 
in combination into the rumen of each goat during the Phase 
A of the experiment. Seed was ground using a Wiley Mill with 
5.0  mm screen. Quantities of ground seed infused daily were 
targeted to provide a diet concentration of ~0.8 μg/g of diet DM 
of ergovaline plus its epimer, ergovalinine. Amounts of seed were 
daily adjusted based on the previous day’s consumption for each 
goat pair. In Experiment 2, toxic seed was replaced with an extract 
of toxic endophyte-infected tall fescue that was generated follow-
ing procedures described by Foote et  al. (22). The extract was 
wrapped in a soft tortilla for infusion in a quantity that targeted a 
diet concentration of 1.1 μg ergovaline/ergovalinine per g DM of 
hay. Ground seed used in Experiment 1 and seed extract used in 
Experiment 2 were from composite of seed samples from bags of 
the endophyte-infected cultivar, “Defiance.” Seed and extract were 
analyzed for concentrations of the ergopeptine, ergovaline, and its 
epimer, ergovalinine, using procedures of Yates and Powell (23) 
and modified as described by Carter et al. (18). Concentrations 
of ergovaline/ergovalinine in the seed averaged 2.33 μg/g, and the 
amount in daily fed seed extract per goat was 722.0 μg.
Chopped orchardgrass–timothy hay was fed ad libitum. Seed 
that was previously coarse-ground using a Wiley Mill with a 5.0-
mm screen was infused into each rumen using a funnel. Feeding 
of hay and rumen infusions were done at 1500 hours each day. 
During the experimental periods, the previous day’s intake for 
each pen was used to estimate intake per goat and the ratio of fed 
chopped hay to rumenally infused seed for providing a daily diet 
concentration of 0.8 μg of ergovaline and ergovalinine, per gram 
of dry matter. Because a 30 ppm dose of biochanin A was found 
to decrease ammonia production in mixed goat rumen bacteria 
in vitro (24), the amount of the Promensil extract needed for each 
goat was based on the amount needed to achieve a biochanin A 
concentration of 30 mg per liter of rumen. The volume of the goat 
rumen was estimated at 8.5 L.
experiment 1
The goats were fed chopped orchardgrass–timothy hay ad libitum 
for 35 days prior to start of infusion treatments. During Phase 
A of the experiment, goats were infused daily with endophyte-
infected seed and isoflavones in amounts that were previously 
discussed. Phase B was conducted with infusion of only the toxic 
ground seed for a 5-day duration.
Color Doppler ultrasound images of the cross-sections of 
the left common carotid artery and left recurrent interosseous 
artery over the scapula-humerus joint were collected using a 
Classic Medical TeraVet 3000 Ultrasound Unit (Classic Universal 
Ultrasound, Tequesta, FL, USA) with a 12L5-VET (12  MHz) 
linear array transducer. Hair was kept clipped with surgical clip-
pers at each site to maintain consistent transducer placement at 
each imaging session. Baseline measures for hay feeding with no 
rumen infusions were collected for each goat on the day before 
and the fourth and fifth days prior to start of infusions for the 
Phase A. Images were collected on days 1, 2, 3, and 4, and during 
Phase B on days 1, 2, 3, 4, and 5. Each imaging session was started 
at ~1100  hours and was done in 30–40  min. Five images were 
collected and stored for each artery using a pulse frequency of 
5.0  MHz. Scan depth was set at 4  cm for the common carotid 
artery and 3 cm for the recurrent interosseous and caudal arteries. 
Following freezing of an individual scan, frames stored in the cine 
memory of the unit were searched to store the image exhibiting 
the maximum flow signal and assumed to be at peak systolic 
phase. The flow signal was traced to estimate lumen area (8).
On the final day on treatment (DOT) for each infusion 
treatment, five longitudinal images of the left common carotid 
arteries also were collected using Pulse Wave Doppler feature to 
measure peak systolic velocity, heart rate, and pulsatility index. 
Pulsatility index was used as an indicator of vascular resistance 
(25). Images were collected on the last DOT that cross-sectional 
images were collected for the two infusion treatments, but not 
for baseline measures. Doppler spectra were collected using a 
Doppler frequency of 5.0 MHz, a correction angle of 60°, and a 
sample volume size of 1.0 mm.
experiment 2
The goats were fed chopped orchardgrass–timothy hay ad libitum 
for 77 days prior to start of infusion treatments. The seed extract 
was rumenally infused daily into each goat for 8  days during 
Phase A, and both the seed extract and isoflavones were infused 
for 6 days during Phase B.
Ultrasound B-mode images of the cross-sections of the left 
common carotid and left recurrent interosseous arteries were col-
lected with a Z. One Ultra SP System (Zonare Medical Systems, 
Inc., Mountain View, CA, USA) using the L14-5W linear array 
transducer. Baseline measures for hay feeding with no rumen 
infusions were collected for each goat on the same days prior to 
initiation of the infusion treatment as for Experiment 1. Another 
FigUre 1 | Ultrasonic measures in experiment 1 of proportionate differences from baseline measures for luminal area of the carotid artery in rumen-
fistulated wether goats that were infused with (a) toxic endophyte-infected tall fescue seed and isoflavones in phase a, and (B) toxic seed only in 
phase B. Baseline measures were taken with goats receiving ad libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum pratense) hay with no rumen 
infusions. Images for determining baseline measures were collected when goats were being adapted to the hay diet on the last, fourth, and fifth days prior to 
initiating the infusion treatments. Asterisks above the bars denote significant differences between treatment and baseline measures at P < 0.05 (*), P < 0.01 (**), and 
P < 0.001 (***) levels of significance. A trend line is provided for Phase B that illustrates the linear relationship between proportionate differences from baseline and 
days on treatment.
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difference from Experiment 1 was that images were collected on 
latter days during each phase when, based on observations in 
Experiment 1, a response was assumed to be present. Images were 
collected during Phase A on days 6, 7, and 8, and during Phase 
B on days 4, 5, and 6. The B-mode images were collected using 
a frequency of 5.0 MHz. Five image clips were stored for each 
artery for freezing the still image exhibiting the maximum flow 
signal and assumed to be at peak systolic phase for measurement 
of lumen diameter and calculation of luminal area. The elastin 
tissue in the endothelial intima was used for tracing the lumen 
and estimating luminal area (8).
Similar to Experiment 1, five longitudinal images of the left 
common carotid arteries also were collected using the Pulse Wave 
Doppler feature to measure peak systolic velocity, mean velocity, 
heart rate, and pulsatility index; however, unlike Experiment 1, 
the images were collected when baseline cross-sectional images 
were collected, and after initiation of infusion treatments on DOT 
when cross-sectional images were collected. Instrument settings 
were the same between both experiments.
statistical analyses
Proportionate differences of luminal areas of arteries during the 
phases from baseline measures were analyzed using mixed models 
of SAS as repeated measures with the autoregressive covariance 
(26). The analysis used individual animals as the experimental 
unit. Infusion treatment, DOT, and the interaction between 
infusion treatment and DOT were analyzed as fixed effects for 
both experiments, and goat and goat ×  fusion treatment were 
evaluated as random effects. Measures from images collected 
when hay was fed with no infusions were averaged for each goat 
and subtracted from measures made during the two phases of 
each experiment, and divided by the average baseline measure 
to estimate the proportionate difference. Infusion treatment was 
analyzed as a discrete variable and DOT was evaluated as a con-
tinuous variable. In the presence of interaction between infusion 
treatment and DOT, least square means for luminal areas in both 
experiments and blood flow rate in the carotid artery measured 
in Experiment 2 were evaluated as being above, below, or similar 
(P < 0.05) to baseline measures. Linear trends over DOT for each 
infusion treatment were determined as described by Littell et al. 
(26) using mixed models.
Blood flow characteristics for the carotid were analyzed using 
the same statistical model as the artery luminal areas, with the 
exception that actual measures and not proportionate differences 
were analyzed. The PDIFF option was used for comparisons of 
least square means between baselines and the two infusion treat-
ments in Experiment 2.
resUlTs
experiment 1
Baseline measures of the carotid luminal areas averaged 
12.1 ± 0.7 mm2. There were no trends over DOT during Phase 
A with infusions of toxic seed and isoflavones. However, carotid 
luminal areas were similar (P >  0.12) to baselines for the first 
2 days, but were greater (P < 0.05) than baselines on days 3 and 4 
(Figure 1). During infusion with only the toxic seed in Phase B, 
there was a linear decline in carotid luminal area over DOT. Mean 
luminal area fell below the baseline by day 3 (26% decrease from 
the baseline measure) and remained proportionately less on day 
4 (45% decrease from the baseline measure).
FigUre 2 | Ultrasonic measures in experiment 1 of proportionate differences from baseline measures for luminal area of the interosseous artery in 
rumen-fistulated wether goats that were infused with (a) toxic endophyte-infected tall fescue seed and isoflavones in phase a, and (B) toxic seed 
only in phase B. Baseline measures were taken with goats receiving ad libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum pratense) hay with no 
rumen infusions. Images for determining baseline measures were collected when goats were being adapted to the hay diet on the last, fourth, and fifth days prior to 
initiating the infusion treatments. Asterisks above the bars denote significant differences between treatment and baseline measures at P < 0.05 (*), P < 0.01 (**), and 
P < 0.001 (***) levels of significance. A trend line is provided for Phase B that illustrates the linear relationship between proportionate differences from baseline and 
days on treatment.
TaBle 1 | Mean responses (±seM) of blood flow characteristics in 
rumen-fistulated wether goats in experiment 1 when toxic tall fescue 
seed and isoflavones were rumenally infused in Phase a and only toxic 
tall fescue seed was infused in Phase B, and in experiment 2 when toxic 
seed extract only was infused in Phase a and toxic seed extract and 
isoflavones were infused in Phase B.
experiment Measure Baseline Phase a Phase B
1 Peak systolic 
velocity, cm/s
29.8 ± 3.6 33.2 ± 2.6
Pulsatility 
index
1.41 ± 0.18b 3.39 ± 0.71a
Heart rate, 
bpm
61 ± 4 63 ± 3
2 Peak systolic 
velocity, cm/s
23.4 ± 1.7 24.1 ± 2.3 20.4 ± 2.0
Pulsatility 
index
1.24 ± 0.11b 1.63 ± 0.13a 1.42 ± 0.13a,b
Heart rate, 
bpm
60 ± 3 52 ± 3 56 ± 3
The infusion treatments were reversed between the two phases in Experiment 2. Goats 
were fed ad libitum chopped orchardgrass–timothy grass hay and baseline measures 
for Experiment 2 were obtained during the adaptation period when the goats were fed 
the hay prior to initiating the infusion treatments.
a,bMeasures within rows with different superscripts are different (P ≤ 0.05).
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Interosseous luminal areas (mean baseline meas-
ure = 2.7 ± 0.1 mm2) with infusions of toxic seed and isoflavones 
during Phase A did not differ from baseline measures, but were 
increasingly less than the baseline over DOT during Phase B 
when only the toxic seed was infused (Figure 2). Mean luminal 
areas were proportionately less than baselines on 2, 3, and 4 DOT 
during Phase B, with ranges in areas relative to the baseline of 
22% at 2 DOT to 45% at 4 DOT.
There were no differences between the infusion treatments 
(Table  1) on peak systolic velocity (P  =  0.47) or heart rate 
(P = 0.712). A greater pulsatility index occurred at the conclu-
sion of Phase B, during which only toxic seed was infused, which 
indicated greater resistance to blood flow with infusion of ergot 
alkaloids and less resistance to blood flow when isoflavones were 
combined with the toxic seed in the infusion.
experiment 2
After being infused with the seed extract for 6 days in Phase A, 
mean carotid luminal areas were proportionately less than base-
line measures (14.5 ± 1.0 mm2) to the same extent over 6, 7, and 
8 DOT (Figure 3), averaging ~41% decrease in area relative to 
the baseline. Carotid luminal area was still less than the baseline 
on day 4 after including the isoflavones with the seed extract; 
however, the areas increased linearly over DOT and were similar 
to baselines on 5 and 6 DOT.
Blood flow rate in the carotid artery responded similarly as 
luminal area of the artery (Figure  4). Flow rates were propor-
tionately less than the baseline measures after fescue seed extract 
infusion (112 ± 10 mL/min.) over 6, 7, and 8 DOT, and the areas 
averaged ~47% of baseline areas. Flow rates increased linearly 
over 4, 5, and 6 days after isoflavones were included in the infu-
sion treatment and were similar to baseline by 6 DOT.
Mean luminal area of the interosseous artery also was stable 
and less than baseline measures (0.7 ± 0.1 mm2) over 6, 7, and 8 
DOT when only the seed extract was infused (Figure 5). Decreases 
in interosseous luminal areas ranged from 34.2 to 41.3% of the 
FigUre 4 | Ultrasonic measures in experiment 2 of proportionate differences from baseline measures for blood flow rate through the carotid artery 
in rumen-fistulated wether goats that were infused with (a) toxic seed extract only in phase a, and (B) toxic seed extract and isoflavones in phase B. 
Baseline measures were taken with goats receiving ad libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum pratense) hay with no rumen infusions. 
Images for determining baseline measures were collected when goats were being adapted to the hay diet on the last, fourth, and fifth days prior to initiating the 
infusion treatments. Asterisks above the bars denote significant differences between treatment and baseline measures at P < 0.05 (*), P < 0.01 (**), and P < 0.001 
(***) levels of significance. A trend line is provided for Phase B that illustrates the linear relationship between proportionate differences from baseline and days on 
treatment.
FigUre 3 | Ultrasonic measures in experiment 2 of proportionate differences from baseline measures for luminal area of the carotid artery in rumen-
fistulated wether goats that were infused with (a) toxic seed extract only in phase a, and (B) toxic seed extract and isoflavones in phase B. Baseline 
measures were taken with goats receiving ad libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum pratense) hay with no rumen infusions. Images for 
determining baseline measures were collected when goats were being adapted to the hay diet on the last, fourth, and fifth days prior to initiating the infusion 
treatments. Asterisks above the bars denote significant differences between treatment and baseline measures at P < 0.05 (*), P < 0.01 (**), and P < 0.001 (***) levels 
of significance. A trend line is provided for Phase B that illustrates the linear relationship between proportionate differences from baseline and days on treatment.
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baseline measures. By 4 DOT after isoflavones were included with 
the seed extract in the infusion, the luminal areas had increased 
and stabilized to areas that were similar to baseline measures.
Peak systolic and mean velocities in the carotid artery did not 
vary (P = 0.889) over DOT for the infusion treatments, and were 
similar (P = 0.338) between baseline measures and both infusion 
treatments (Table 1). Heart rate also did not differ (P = 0.339) 
between the baseline and infusion treatments. Pulsatility index 
with the seed extract infusion was greater (P = 0.025) than the 
baseline measure, but decreased back to indices that were similar 
FigUre 5 | Ultrasonic measures in experiment 2 of proportionate differences from baseline measures for luminal area of the interosseous artery in 
rumen-fistulated wether goats that were infused with (a) toxic seed extract only in phase a, and (B) toxic seed extract and isoflavones in phase B. 
Baseline measures were taken with goats receiving ad libitum chopped orchardgrass (Dactylis glomerata)–timothy (Phleum pratense) hay with no rumen infusions. 
Images for determining baseline measures were collected when goats were being adapted to the hay diet on the last, fourth, and fifth days prior to initiating the 
infusion treatments. Asterisks above the bars denote significant differences between treatment and baseline measures at P < 0.05 (*), P < 0.01 (**), and P < 0.001 
(***) levels of significance.
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(P = 0.25) to the baseline average when isoflavones were included 
with seed extract in the infusion.
DiscUssiOn
The focus of this research was to investigate if isoflavones can 
mitigate the adverse effects of ergot alkaloids on the hemodynam-
ics of goats. Persistent constriction of blood flow to peripheral 
tissues incapacitates the animal’s ability to thermoregulate their 
core body temperature. This causes animals being vulnerable to 
severe heat stress under moderate ambient temperatures. Recent 
research has reported ergot alkaloid-induced vasoconstriction of 
the ruminal artery and vein (27), and mesenteric vasculature (28) 
in cattle. These results provided strong evidence that exposure 
to ergot alkaloids can have a negative influence on nutrient 
efficiency.
Low prolactin concentrations are often used as an indicator 
that animals are suffering from fescue toxicosis. It would have 
been informative to monitor serum prolactin concentrations 
in the present experiment with goats; however, it was critical 
to control goat temperament and nervousness for accurate 
measurement artery lumen areas and blood flow characteristics. 
Although body temperature measures and collection of blood 
for assaying prolactin concentrations would have been informa-
tive, they would likely have caused extraneous error in the ultra-
sound measures that were necessary in meeting experimental 
objectives.
The diet concentrations of isoflavones used in the experiments 
were based on the concentration needed to decrease ammonia 
production in vitro (24). However, it should be mentioned that 
selectivity of clovers relative to grasses and other forages could 
be such that typical diet concentrations of isoflavones are much 
lower or higher than what is used in the present experiment. 
Dose–response experiments and grazing experiments with 
clover–grass mixtures will be needed to determine optimum diet 
concentrations of isoflavones for mediation of a response.
experiment 1
Ergovaline is the ergopeptine that is consistently in the highest 
concentration in toxic endophyte-infected tall fescue (29) and also 
has demonstrated to be the most potent ergopeptine produced by 
the tall fescue endophyte in mediating a vasoconstrictive response 
in bovines (30, 31). Aiken et al. (32) reported a vasoconstrictive 
response of the caudal arteries of endophyte-naïve heifers in less 
than 48 h after initial consumption of diets containing ground 
tall seed in quantities that provided ergovaline concentrations of 
0.8 μg/g DM.
Carotid and auricular arteries in goats were reported by 
Aiken and Flythe (11) to exhibit a vasoconstrictive response 
in 2  days after initial consumption of a diet containing 0.8 μg 
ergovaline  +  ergovalinine/g DM. Responses in Experiment 1 
were similar between the carotid and interosseous arteries. A diet 
concentration similar to that used by Aiken and Flythe (11) was 
fed in the preset experiment, but alkaloid-induced vasoconstric-
tion did not occur over the first 4 days when rumens were infused 
with both toxic seed and isoflavones. There did, however, appear 
to be vasodilation of the carotid artery at 3 and 4 DOT. The strong 
linear decline in luminal areas after isoflavones were removed 
from the infusion provided evidence that isoflavones mediated 
vaso-relaxation of the carotid artery. Similar to the findings of 
Aiken and Flythe (11), significant vasoconstriction occurred at 2 
DOT when only the toxic seed was infused.
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Higher pulsatility reflects greater resistance to blood flow; 
thus, greater blood flow resistance was observed on 4 DOT 
with infusions lacking isoflavones. Greater peak systolic velocity 
could also be expected with higher pulsatilities, but there can be 
considerable error in these measures due to between-animal and 
between-image variations. Aiken and Strickland (33) warned that 
placement of the sample gate within the vessel and animal tension 
could be major sources of variation between images.
experiment 2
Based on reduced luminal areas of both arteries at 6, 7, and 8 
DOT during phase A when only the seed extract was infused, the 
arteries appeared to have been saturated with ergot alkaloids. This 
is because the luminal areas at each of these latter DOT were less 
than the baselines and with no declining trends. Furthermore, 
blood flow rates in the carotid were similar to the responses 
for the luminal areas to seed extract over DOT. Luminal area 
and blood flow rate for the carotid were less than baselines on 
4 DOT, but linear increases over the latter DOT indicated that 
the areas and blood flows were back to baseline levels by 5 DOT 
with inclusion of isoflavones in the infusion. Luminal areas of 
the interosseous artery did not exhibit increases relative to the 
baseline, but were similar to baseline at each of the three DOT; 
therefore, vaso-relaxation had occurred prior to 4 DOT.
The responses of the carotid arteries to isoflavones appeared to 
be gradual during the phase; however, measures were needed at 
earlier DOT to verify that trend. Again, saturation of the carotid 
was indicated to have occurred in Phase A, which could have 
been a factor in early mitigation of the vasoconstriction. The miti-
gation of vasoconstriction of the interosseous artery might have 
occurred earlier than 4 DOT, which suggests that there could be a 
greater density of β-adrenergic receptors in the interosseous than 
carotid artery.
It is curious that baseline measures of mean luminal area of 
the interosseous were almost fourfold greater in Experiment 1 
than in Experiment 2. This was likely related more to the methods 
of measuring luminal area and not to differences in accuracy 
between the two ultrasound instruments, which was checked. 
Aiken et al. (8) concluded that tracing connective tissue in the 
intima with a B-mode image could overestimate luminal area and 
tracing the color Doppler signal could underestimate the signal. 
However, it was difficult without using the color Doppler signal as 
a guide to take the measures at the true peak systolic phase of the 
cardiac cycle because of a weaker pulse of the interosseous artery, 
as compared to the carotid artery. Tracing the color Doppler sig-
nal offers more accuracy in taking measures at the peak velocity 
during a cardiac cycle, whereas relying on weaker pulses without 
color Doppler could cause errors in detection of peak systolic 
velocity that would lead to underestimation of luminal area.
Peak systolic velocity and heart rate were not affected by either 
infusion treatment; however, the least square mean for pulsatility 
index was greater for the seed extract without than with isofla-
vones, and the baseline measure. Similar mean pulsability indices 
between the baseline and the seed extract and isoflavone infusion 
further indicated that isoflavones mitigated resistance to blood 
flow mediated by the alkaloid-induced vasoconstriction.
Jia et  al. (34) examined the interaction of the isoflavones, 
formononetin and biochanin A, and tall fescue seed extract 
on the vasoactivity of bovine mesenteric arteries and veins. In 
these experiments, the two isoflavones tested did not mitigate 
vasoconstriction, which superficially appears to contradict the 
results presented here. However, comparison of the studies is 
informative. The most obvious difference is that the experiment 
performed by Jia and co-workers was in vitro, on a myograph, 
and with different blood vessels than those monitored in the 
current study. It is well established that β-adrenergic receptors 
are differentially expressed in tissue types across species (35, 36). 
Thus, isoflavones could have greater impact on some regions of 
the vascular system than others, which is consistent with the 
activity of known β-adrenergic agonists, such as ractopamine 
(37). Second, the mesenteric arteries and veins were exposed 
to the isoflavones for 2 h prior to the myograph measurements, 
while the goats received the isoflavones in the rumen daily. 
Microorganisms metabolize some isoflavones in the rumen (38). 
For example, formononetin is converted into daidzein and then 
equol, which undergoes renal clearance (39, 40). The detection of 
equol in the urine indicates that equol, rather than formononetin, 
was present in the blood.
When the results of the current study and the results of Jia and 
co-workers are considered together several plausible hypotheses 
emerge, including (1) clover isoflavones mitigate vasoconstriction 
in the carotid and interosseous arteries, but not in the mesenteric 
artery and vein; (2) exposure periods longer than 2 h are required; 
and (3) the biologically active forms are microbial metabolites of 
the clover isoflavones. Differences in animal species should also 
be considered, but previously demonstrated activities in a variety 
of animals (including humans and rodents) make differences 
between the two ruminant species the less likely possibility (16, 
19, 12). It is also possible that the amounts of isoflavones in the 
fed tablets were underestimated. The amounts determined in this 
study were about 25% of the total isoflavone content reported on 
the product label. The discrepancy may reflect differences in the 
extraction or the quantitation methods used. It may also be due to 
the isoflavone extraction employing 30 min of sonication at ambi-
ent temperature instead of refluxing (15 min) at 85°C, the method 
used by Krenn et  al. (41). Sonication for 30  min in acidified 
methanol has thoroughly extracted phenolic compounds from 
fruits and vegetables in other studies (42). However, it is possible 
that the sonication did not completely extract isoflavones from 
the clover tissue. In that case, the amount of isoflavones avail-
able to the animal may have exceeded the amounts determined 
by the tablet analysis, although it is difficult to determine how 
the amounts extracted by acidified methanol would compare to 
the amounts extracted by rumen microorganisms in an aqueous 
environment.
cOnclUsiOn
Results indicated that isoflavones in the diet of goats grazing 
toxic endophyte-infected tall fescue can counter and relieve 
ergot alkaloid-induced vasoconstriction. Although results from 
Experiment 2 indicated that relief with isoflavones can occur 
after goats are exposed to ergot alkaloids, it is uncertain if the 
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vasculature of the goats was saturated with ergot alkaloids, which 
could have had a bearing on efficacy of the treatment. More 
experiments are needed to verify the responses and evaluate 
dose–responses for determining threshold concentrations of 
isoflavones in the diet for mediating a positive response by the 
vasculature. Furthermore, the rapidness of the responses to both 
ergot alkaloids and isoflavones were such that valid interpreta-
tions and conclusions could be made using Latin square types of 
experimental designs, which will be necessary if environmental 
controls are not possible. Nonetheless, these results provide strong 
evidence that isoflavones produced by legumes can ameliorate the 
adverse effects of fescue toxicosis.
Studies with cattle, sheep, and horses should be conducted 
to determine if alkaloid-induced vasoconstriction can be 
relaxed with exposure to isoflavones. Given that isoflavones 
ameliorate alkaloid-induced vasoconstriction in grazing 
livestock, management approaches can be developed to utilize 
isoflavone containing clovers and other legumes in pastures 
or feed additives to alleviate or mitigate severe heat stress 
suffered by animals grazing toxic tall fescue in moderate air 
temperatures. Relaxation of alkaloid-induced vasoconstriction 
from consumption of isoflavones could alleviate or mitigate the 
adverse effects of ergot alkaloids on blood circulation and the 
ability to thermos-regulate core body temperature. This could 
ultimately enhance dry matter intake and improve overall ani-
mal performance and well-being. However, findings from the 
present experiments should be verified with replicated grazing 
trials that use a higher number of animals and with longer term 
exposure to ergot alkaloids.
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